Laddar...
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
BACKGROUND: Elderly patients with chronic kidney disease (CKD) are usually at a high risk of fractures due to both osteoporosis and CKD-mineral bone disease (MBD). A new marker is needed to prevent fractures and control CKD-MBD from the early to advanced stages of CKD. In the early stage of CKD, fib...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3506497/ https://ncbi.nlm.nih.gov/pubmed/23013306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-13-122 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|